Albanian doctor in Germany: Here's when the coronary vaccine is ready.

Albanian physician in Germany Dr. Shkelqim Reci tells of the Albanian newspaper “The Albanian diaspora” as far as the German state has walked in finding a choreography vaccine.

Furthermore, it explains the entire process of realising a vaccine to a previously unknown virus. Also, Dr. Reci underlined that the production of a qualitative vaccine that does not provide side effects and stimulates the body to produce as efficient answers as possible takes its own production and testing time.

How does a vaccine develop against an unknown new virus?

First, pathogen is analyzed and studied in which components of the virus the human immune system reacts to and forms protection. Studies so far show that:

In the event of a SARS-COV-2 infection, the body begins to protect itself, and in the first week it starts producing antibodies and also activates its cell immune system. This is where the vaccine model begins and develops. So the virus part is studied where our immune system reacted.

Only after experiments, studies and extensive investigations and evidence that vaccines can be produced in good quality is it tested in clinical trials from stage I to stage III.

Testing is done in participants or students who volunteer. If all results of preliminary and clinical evidence are available, and with positive results, then a request is made for application or approval of the vaccine (in line with European standards). After receiving approval, the vaccine can then be traded and used in people. So these RNA vaccines are modern biomedical vaccines.

What exactly does this vaccine contain?

This vaccine contains part of the virus's genetic material, which includes structure or superficial protein components of the SARS-CoV 2 ( SARS Hospital CoV 2 or part of it. Following the application of the vaccine or its composition, our immune system reacts and begins producing antibodies.

And if the vaccinated person later comes into contact with pathogen or is infected by SARS CoV-2, the immune system recognizes the surface structure of the SARS CoV 2, and specifically it can fight and avoid this relevant SARS-CoV -2 virus directly. So we low doses stimulate an immune response to antibodies and T cells.

What does a clinical test of a specific vaccine mean against David-19?

The purpose of the clinical test is to gain knowledge of a medical product that will be used in humans. It will be tested in clinical trials from Stage I to Faza III.

It begins with phase I, in a small group of fewer volunteers (<100) testing tolerance or compatibility, the safety of use, and the definition of the first dose.

Stage II, (>100 to <1,000 volunteers) assign the dosage and specify a vaccine program (e.g. one or two vaccines as well as the benefit of knowledge regarding security and efficiency.

Stage III (over 1,000 volunteers, or patients), where efficiency, detection of side effects will be tested in large numbers of volunteers or patients. Such situations also present or examine opportunities for speeding up the process.

When can the results of this clinical test be expected?

The health system can be heavily overloaded during the current SARS-CoV-2 pandemic, so it is important to maintain good general health in the population to facilitate the health system. According to the Federal Institute for Vaccina and Barna Biomedecare in Germany, the first results could be expected after two to three months.

And when can human vaculation begin?

The way a vaccine works, with the presence of an antigen or a virus in your body, your body will start producing antibodies in response to the immune virus. Therefore, to produce a quantum vaccine, to have no side effects, and to encourage your body to produce as effective immune answers as biologically possible. I suppose there's going to be some different vaccines in the market soon, I can't say when right. But will this immunity be the same as natural immunity we will have to see!